Tatva Chintan Pharma Chem Ltd.

•

tatvachintan.comBSE: 543321NSE: TATVA

Market Cap₹ 3,756 Cr.

Current Price

High / Low₹ 1,838 / 982

Stock P/E84.6

Book Value₹ 329

Price to Book3.24

Dividend Yield0.12 %

ROCE6.9 %

ROE5.3 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Structure Directing Agents: 40.7% • Pharmaceutical & Agrochemical intermediates & Other Specialty Chemicals: 33.1% • Phase Transfer Catalysts: 23.1%

AI Sector View

AI GENERATED

Chemicals

Hold

The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.

Confidence

55%

View full sector analysis →

PROS

Latest quarter profit grew 103.6% YoY, showing strong momentum
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.27x)
Operating margins have improved to 18.0% from 15.0%
Working capital cycle has improved - days down from 151 to 83
Company comfortably covers its interest (18.7x coverage)
Company has a consistent dividend-paying track record

CONS

Receivables are growing faster than sales - a possible quality concern
Company has a low return on capital employed of 4.7%
Company has a low return on equity of 3.4% over last 3 years
Total debt has risen sharply - up 230.8% year on year
Free cash flow has been persistently negative
Company has delivered a poor profit growth of -5.3% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

ChemicalsChemicalsChemicals

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SOLARINDS	22307.50	101.37	201860.69	0.05	666.37	88.98	3668.20	70.26	38.16	27.91
2.	PIDILITIND	1567.45	60.23	159547.55	1.37	8835.10	1202.86	45515.50	1112.74	32.38	26.28
3.	SRF	2483.00	34.05	73602.28	0.36	758.87	75.53	5033.26	34.63	14.21	24.57
4.	FLUOROCHEM	4771.75	85.23	52417.67	0.06	219.00	19.02	1588.00	23.97	9.58	26.83
5.	NAVINFLUOR	8541.10	55.49	43822.77	0.18	243.31	107.67	1045.08	44.07	21.39	34.17
6.	GODREJIND	1127.00	32.29	37963.11	0.00	523.36	-27.85	5448.09	22.16	10.64	12.82
7.	AETHER	1672.95	94.41	22204.70	0.00	62.75	33.45	326.56	27.49	11.65	31.47
8.	DEEPAKNTR	1587.10	27.64	21646.94	0.47	345.01	207.36	2577.60	36.39	11.58	20.96
9.	ATUL	6244.55	23.11	18385.05	0.48	253.93	91.85	1847.95	25.03	15.05	21.41
10.	AARTIIND	492.15	33.62	17851.59	0.20	155.00	260.47	2387.00	42.42	6.95	16.00
11.	DEEPAKFERT	1320.45	17.00	16725.20	0.76	490.04	100.95	3256.26	22.47	12.12	25.96
12.	TATVA	1605.65	73.10	3755.95	0.12	15.98	140.28	167.06	42.95	7.17	19.33

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	106	93	86	94	94	81	84	108	109	116	139	133	147
	86	72	74	80	86	76	78	100	94	95	112	106	135
Operating Profit	20	21	12	14	8	5	6	8	15	21	27	27	11
OPM %	18.49%	22.40%	14.30%	15.12%	8.21%	5.68%	6.73%	7.34%	13.80%	18.22%	19.21%	20.00%	7.76%
	1	1	1	5	1	1	0	1	1	1	2	-0	5
Interest	3	3	0	0	0	0	0	0	0	1	0	1	2
Depreciation	6	7	7	6	7	7	7	7	9	9	9	10	11
Profit before Tax	12	12	7	12	2	-2	-2	2	7	12	19	15	14
Tax %	29.61%	29.89%	29.12%	32.82%	29.44%	29.75%	29.70%	29.68%	27.23%	27.55%	14.95%	39.72%	25.88%
Net Profit	8	8	5	8	2	-1	-1	1	5	9	16	9	10
	3.72	3.63	1.99	3.52	0.64	-0.47	-0.50	0.47	2.19	3.82	6.84	3.86	4.47

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	109	129	203	254	291	428	403	379	366	496	534
	83	109	170	201	226	322	348	312	340	407	448
Operating Profit	26	21	33	53	65	106	55	67	26	89	86
OPM %	23.73%	15.86%	16.36%	20.76%	22.46%	24.78%	13.60%	17.70%	7.10%	18.03%	16.04%
	5	5	1	1	5	11	2	8	4	4	8
Interest	2	3	4	4	4	5	9	7	1	3	5
Depreciation	2	4	4	5	7	8	10	26	28	37	38
Profit before Tax	27	18	26	44	59	103	39	42	0	53	60
Tax %	36.70%	35.20%	23.62%	20.93%	13.46%	7.05%	-4.21%	30.56%	29.07%	26.49%	26.26%
Net Profit	17	12	20	35	51	96	40	29	0	39	44
EPS	21.54	14.82	10.05	17.41	25.57	44.65	18.26	12.55	0.14	16.71	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	19.56%	4.62%	10.96%	15.94%	715.31%	11.97%	—

COMPOUNDED SALES GROWTH

10 Years:: 19%
5 Years:: 11%
3 Years:: 7%

COMPOUNDED PROFIT GROWTH

10 Years:: 18%
5 Years:: -5%
3 Years:: -1%

STOCK PRICE CAGR

10 Years:: —
5 Years:: -5%
3 Years:: -1%
1 Year:: 59%

RETURN ON EQUITY

10 Years:: 21%
5 Years:: 10%
3 Years:: 3%
Last Year:: 5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	8	8	8	8	20	22	22	23	23	23
	41	53	72	106	142	447	483	702	698	735
	47	57	71	79	92	120	170	11	36	121
Trade Payables	18	24	22	31	47	44	32	44	32	57
	9	5	14	20	19	35	34	22	21	51
Total Liabilities	123	146	187	245	320	667	740	803	811	987
	13	56	67	111	120	160	196	427	529	609
Capital Work in Progress	27	10	6	5	10	51	231	73	22	23
	1	2	1	1	1	1	1	11	1	5
	20	24	31	59	68	161	151	144	123	169
	0	0	0	0	0	0	0	68	90	144
Cash & Bank	18	8	16	10	4	175	39	37	12	4
	43	46	67	60	117	120	123	43	34	32
Total Assets	123	146	187	245	320	667	740	803	811	987

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	35	18	14	32	29	38	31	103	24	29
Cash from Investing	-25	-24	-17	-40	-21	-197	-101	-121	-65	-116
Cash from Financing	15	1	17	10	-5	235	38	31	17	79
	15	-10	8	-6	-6	58	-40	13	-25	-8

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	72.02	72.02	72.02	72.02	72.02	72.02	72.02	72.02	72.02
	3.37	3.33	3.36	3.30	3.26	3.40	4.17	3.81	3.93
	10.64	6.83	6.34	5.46	5.11	3.87	3.32	2.99	3.11
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	13.98	17.82	18.28	19.22	19.60	20.73	20.48	21.17	20.94

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-08

Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-08 - Tatva Chintan Pharma Chem Limited has informed the Exchange about Schedule of meet

2026-09-08

Credit Rating

2026-09-08 - Tatva Chintan Pharma Chem Limited has informed the Exchange about Credit Rating

2026-08-28

Copy of Newspaper Publication

2026-08-28 - Tatva Chintan Pharma Chem Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-27

Record Date

2026-08-27 - Tatva Chintan Pharma Chem Limited has informed the Exchange that Record date for the purpose of Dividend is 11-Sep-2026.

2026-08-27

Updates

2026-08-27 - Tatva Chintan Pharma Chem Limited has informed the Exchange regarding ' Business Responsibility and Sustainability Report for the FY 2025-26'.

2026-08-27

Shareholders meeting

2026-08-27 - Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026

2026-08-19

Resignation of Director/KMP/SMP

2026-08-19 - Tatva Chintan Pharma Chem Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-19

Resignation

2026-08-19 - Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Resignation of a Senior Management Personnel of the Company.

2026-08-18

Copy of Newspaper Publication

2026-08-18 - Tatva Chintan Pharma Chem Limited has informed the Exchange about Copy of Newspaper Publication